HindustanTimes Mon,22 Sep 2014

Dr Reddy's Lab Q2 profit up 69% at Rs. 690 crore

PTI  New Delhi, October 31, 2013
First Published: 15:30 IST(31/10/2013) | Last Updated: 15:41 IST(31/10/2013)
Drug major Dr Reddy's Laboratories on Thursday reported a 69.41% increase in consolidated net profit at Rs. 690.25 crore for the second quarter ended September 30.

The company had posted a profit of Rs. 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs. 3,357.45 crore from Rs. 2,880.85 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing. Revenue from the global generics segment grew 32% to Rs. 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
Shares of Dr Reddy's Laboratories were down 2.52% at Rs. 2,459.20 on the BSE in late afternoon trade.

more from Business

Airlines oppose govt policy on connectivity to remote areas

Airlines and private charter operators have opposed the government's draft policy on air connectivity to regional and remote areas, saying it will have severe impact on their financial strength.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved